Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors
The DOI matches its Crossref record.
Abstract
Hepatotoxicity is an adverse effect of all available classes of antiretrovirals, including nucleoside reverse transcriptase inhibitors (NRTI). A syndrome of hepatic steatosis and lactic acidosis has been recognized as a rare, potentially fatal complication since the advent of NRTI monotherapy in the early 1990s. Today, NRTI remain the backbone of antiretroviral combination regimens, and, with the success of current treatment strategies, exposure to two or more of these agents may occur over a number of years. Hepatic steatosis and lactic acidosis are accordingly being observed more frequently, along with a more recently recognized syndrome of chronic hyperlactatemia. These as well as other adverse effects of NRTI are mediated by inhibition of human DNA polymerase gamma, resulting in mitochondrial dysfunction in the liver and other tissues. Early recognition and intervention are essential to avert serious outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although mouse studies suggest that NRTIs are an effective treatment option for L1-driven age-associated inflammation and pathologies, chronic NRTI treatment has been shown to induce adverse side effects in human patients, such as hepatotoxicity, as it also inhibits the mitochondrial DNA polymerase γ (Montessori et al., 2003; Wu et al., 2017).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Montessori et al., 2003
Citations
Cites
Still being checked.
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
David, S., & Hamilton, J. P. (2010) · PubMed · Cited by 399
Han, D., Dara, L., Win, S., Than, T. A., Yuan, L., Abbasi, S. Q., Liu, Z.-X., & Kaplowitz, N. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.009 · Cited by 196
Metadata
- Authors
- Montessori, V., Harris, M., & Montaner, J. S. G.
- Affiliations
- University of British Columbia (CA)
- BC Centre for Excellence in HIV/AIDS (CA)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003
- Volume
- 23
- Issue
- 2
- Pages
- 167-172
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2464563939
- Cited by
- 62
- References
- 0
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2019: 4 · 2018: 3 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 4
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- nucleoside reverse transcriptase inhibitors, hepatotoxicity, lactic acidosis, hepatic steatosis, mitochondrial dysfunction, antiretroviral therapy, HIV infection, adverse drug reactions
- MeSH terms
- Humans, Liver, Mitochondria, Liver, HIV Infections, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors. https://app.cochat.ai/papers/10.1055/s-2003-39947
- The paper
- Montessori, V., Harris, M., & Montaner, J. S. G. (2003). Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors. Seminars in Liver Disease. https://doi.org/10.1055/s-2003-39947
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.